United States: MedPAC Takes Anti-POD Stance In Report To Congress, Echoing An Increasingly Uniform Consensus

On June 15, 2017, the Medicare Payment Advisory Commission (MedPAC), a non-partisan group that advises Congress on Medicare policy, released its annual Report to the Congress on Medicare and the Health Care Delivery System (the "Report"). Of particular importance to some hospitals and physicians, the Report includes MedPAC's first-ever discussion of physician-owned distributorships of implantable medical devices (PODs), and specifically calls for actions to "reduce the number" of PODs. Echoing the findings of prior governmental investigations, the Report also notes that PODs can lead and have led to increased costs and inappropriate care.

MedPAC's commentary follows on the heels of a 2016 report critical of PODs from the majority staff of the Senate Finance Committee (SFC), which, as we discussed in a recent article in Compliance Today, concluded among other things that PODs are "harmful to patients and payers." The Report builds on an ever-increasing consensus of policymakers, regulators, law enforcement, consumer groups, health care providers, and other stakeholders—including the SFC, the Office of Inspector General of the U.S. Department of Health and Human Services (OIG), the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Justice (DOJ), the Association for Medical Ethics, and the Advanced Medical Technology Association (AdvaMed)—that the conflict of interest inherent in the POD business model should be eliminated.

MedPAC's Report includes a discussion of issues that critics have sounded regarding PODs, including that they may lead to increased volume of surgery, increased intensity of procedures, inappropriate care, and higher device costs. It also provides considerations for potential policy changes:

  1. Improve Open Payments Reporting and Monitoring. MedPAC observed that few PODs report through the Sunshine Act Open Payments reporting system—it indicated that it was able to identify a total of only 22 PODs in 2015 reporting data. In part, that low volume may be due to the fact that under the current regulatory interpretation of the Sunshine law, PODs that do not manufacture the implants ordered by their physician-owners are deemed exempt from reporting if they sell to only one hospital (and thus do not meet the regulatory definition of "Group Purchasing Organization" required to disclose payments to physicians). MedPAC also suggested that the low number may be due in part to PODs having changed how they compensate physicians "to circumvent reporting requirements." Additionally, MedPAC indicated that the low volume of disclosures could be partially due to the fact that current Open Payments data are not transparent regarding the type of reporting entity, making it difficult to identify PODs definitively. Based on its findings, MedPAC suggested policy changes that would do the following:

    • Require all PODs to report under the Open Payments program.
    • Require each disclosing entity to indicate whether it is a POD, and what type of products it makes or distributes.
    • Require CMS to coordinate with OIG and to remind PODs or suspected PODs of their reporting obligations, and to impose penalties for non-compliance.
  2. Reduce Prevalence of PODs. MedPAC's Report went further than merely suggesting increased transparency, commenting that actions also should be taken "to reduce the number of PODs." It suggested that such measures could include revisions to physician self-referral regulations, presumably a reference to changes that could be made to the regulations implementing the Stark Law (or the Anti-Kickback Statute). Another measure to reduce the number of PODs could be to require that hospitals adopt policies that curtail purchases from PODs. This consideration is not included in the Report, but is one that was suggested by MedPAC staff to the commissioners in April, and echoes similar recommendations made in 2016 in the SFC report.

The MedPAC commentary adds the voice of Congress's chief advisor on Medicare payment issues to a decade-long trend ringing increasingly loud alarm bells about PODs:

  • 2008: CMS expresses concern that PODs may "serve little purpose other than providing physicians the opportunity to earn economic benefits in exchange for nothing more than ordering medical devices or other products that the physician-investors use on their own patients."
  • 2011: SFC (then) minority staff releases its first report questioning the propriety of PODs, observing "[t]he very nature of PODs seem to create financial incentives for physician investors to use those devices that give them the greatest financial return and that, in the process, patient treatment decisions may be based on personal financial gain."
  • 2013: OIG issues its Special Fraud Alert (SFA) enumerating elements exhibited by PODs that make them "inherently suspect" under the Anti-Kickback Statute, including features common in the POD business model, such as:

    1. the POD offers investment interests primarily or exclusively to physicians who are expected to order or recommend implants sold by the POD;
    2. the POD primarily or exclusively serves its physician-owners' patient base;
    3. physician-owners shift to the POD's products on a primary or exclusive basis after joining a POD;
    4. physician-owners condition their referrals to hospitals by coercion (such as threats that they will go elsewhere unless the hospital buys implants sold by the POD); and
    5. physician-owners are few enough in number that the volume or value of a physician's own referrals correlates closely to investment return.
  • 2013: OIG also publishes the results of its research into actual hospital purchases from PODs, concluding that PODs result in increased utilization of implantable devices compared to procedures performed with implants not acquired by PODs, and yield no cost savings (and in some cases increase costs).
  • 2014: DOJ files a civil case against Reliance Medical Systems LLC (Reliance), two of Reliance's affiliated PODs, and some of their investors for violations of the Anti-Kickback Statute and the False Claims Act. The Complaint is based on the legal theory that physician-owner return on investment in Reliance PODs constitutes a kickback to induce the physicians to order Reliance implants for their own patient procedures, resulting in the submission of false claims to Medicare.
  • 2016: SFC majority staff releases its second report on PODs, relying on evidence collected from its investigations, and stating in stronger terms that the committee is "highly concerned about the damage that PODs have done, and are continuing to do, to patient safety and federal healthcare programs."
  • 2017: A physician involved in the Reliance case is sentenced to 19 years, seven months in prison for $2.8 million in criminal healthcare fraud. The physician admitted to persuading a hospital where he performed procedures to buy the implants that he ordered for those procedures from a Reliance POD, Apex Medical Technologies, in which he had ownership stake. Additionally, the physician conceded that economic benefits of the POD motived him to perform medically unnecessary surgeries.

Despite its forceful denunciation of the POD business model, it is unlikely that the Report will lead to any immediate actions by Congress or Medicare regulators. Congress's attention to health care currently is focused on the "repeal and replace" of Obamacare (which we discuss here), and CMS is similarly involved with considering whether and how to move forward with several Obama Administration initiatives, such as value-based health care (which we discuss here). However, it is significant that another independent inquiry, this one by Congress's chief non-partisan advisor on Medicare policy, has concluded that physician self-referral to PODs ought to be curtailed. The Report will add another arrow to the quiver of False Claims Act qui tam relators and law enforcement as they challenge POD relationships. Moreover, in the aftermath of the OIG's 2013 SFA and subsequent report, many hospitals adopted policies forbidding or severely restricting dealing with PODs that exhibit any of the SFA's suspect characteristics. Together with the SFC's 2016 report, MedPAC's commentary will make it that much harder for hospitals and physicians to initiate or maintain relationships with PODs.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.